Agilon Health Inc is a healthcare company that focuses on transforming the delivery of primary care through its innovative platform designed for value-based care
By partnering with primary care physicians, Agilon enhances their capabilities and support systems, allowing them to improve patient care and outcomes while managing costs more effectively. The company leverages data analytics and technology to enable a seamless integration of services, facilitating better health management for patients and creating a sustainable model for healthcare providers. Through its collaborations, Agilon is dedicated to creating a more efficient healthcare experience that prioritizes wellness and preventive care.
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Healthcare services company Agilon Health (NYSEAGL) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 44.2% year on year to $1.52 billion. On the other hand, next quarter’s revenue guidance of $1.5 billion was less impressive, coming in 12% below analysts’ estimates. Its GAAP loss of $0.26 per share was 14.8% below analysts’ consensus estimates.
The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
agilon health, inc. (NYSEAGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the fourth quarter and fiscal year ended December 31, 2024.
agilon health, inc. (NYSEAGL), the trusted partner empowering physicians to transform health in our communities, announced that it will participate in the 45th Annual TD Cowen Healthcare Conference including a fireside chat presentation on Wednesday, March 5 at 9:50 AM Eastern Time.
agilon health, inc. (NYSEAGL), the trusted partner empowering physicians to transform health in our communities, announced that it will release its financial results for the fourth quarter and full year 2024 after the market closes on Tuesday February 25, 2025, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results.
agilon health, inc. (NYSEAGL), the trusted partner empowering physicians to transform health care in our communities, announced that its Accountable Care Organizations (ACOs) achieved $150 million in gross savings (13% gross savings rate), including $37 million savings to the Medicare Trust Fund, during the 2023 performance year of the ACO Realizing Equity, Access and Community Health (ACO REACH) model. agilon’s eight REACH ACOs operate under full risk, and in 2023 were responsible for the total cost and quality of care for approximately 90,000 Traditional Medicare beneficiaries.
agilon health, inc. (NYSEAGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the third quarter ended September 30, 2024.
agilon health, inc. (NYSEAGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the 2024 Wolfe Research Healthcare Conference including a fireside chat presentation on Tuesday, November 19, at 2:20 PM Eastern Time.
NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc. (NYSEAGL) on behalf of long-term stockholders following a class action complaint that was filed against Agilon on March 19, 2024 with Class Period (1) Agilon common stock purchases traceable to the April 2021 initial public offering of Agilon stock; (2) pursuant, or traceable, or both, to materials issued in connection with the Company’s secondary public offering that occurred on or about May 16, 2023; and/or (3) common stock between April 15, 2021 and February 27, 2024. Our investigation concerns whether the board of directors of Agilon have breached their fiduciary duties to the company.
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into agilon health, inc. (“agilon” or the “Company”) (NYSEAGL).
